School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. Search for other works by this author on: School of Pharmacy, Faculty of Medicine, The Chinese ...
Opna Bio, South San Francisco, California.
Cancer Discov (2025) 15 (12): 2422–2430.
Department of Metabolism & Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
AbstractBackground:. The sensitivity of a cancer screening biomarker to detect prevalent preclinical cancer drives screening benefit. Studies estimate sensitivity at different points in the biomarker ...
Abstract. Pancreatic cancer is one of the leading causes of cancer-related deaths, highlighting the urgent need for innovative treatment strategies. Histotripsy is a non-invasive, non-ionizing, ...
EpimAb Biotherapeutics Inc, Shanghai, China.
The combination of anti-TROP2 ADCs with PD-(L)1 inhibitors represents a promising therapeutic strategy, merging targeted therapy with immunotherapy to improve treatment outcomes. Clinical trials are ...
Search for other works by this author on: ...
Affinity Biopharmaceutical Co., Ltd., Shanghai, China.
MediLink Therapeutics (Suzhou) Co., Ltd., Suzhou, China.
1Department of Oncology, Mayo Clinic, Rochester, Minnesota.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results